Authors:
GAUSE BL
SHARFMAN WH
JANIK JE
CURTI BD
STEIS RG
URBA WJ
SMITH JW
ALVORD WG
LONGO SL
Citation: Bl. Gause et al., A PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, INTERFERON-ALPHA, AND TAMOXIFEN FOR PATIENTS WITH METASTATIC MELANOMA, Cancer investigation, 16(6), 1998, pp. 374-380
Authors:
CURTI BD
OCHOA AC
POWERS GC
KOPP WC
ALVORD WG
JANIK JE
GAUSE BL
DUNN B
KOPRESKI MS
FENTON R
ZEA A
DANSKYULLMANN C
STROBL S
HARVEY L
NELSON E
SZNOL M
LONGO DL
Citation: Bd. Curti et al., PHASE-I TRIAL OF ANTI-CD3-STIMULATED CD4(-CELLS INFUSIONAL INTERLEUKIN-2, AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED CANCER() T), Journal of clinical oncology, 16(8), 1998, pp. 2752-2760
Authors:
YOE J
GAUSE BL
CURTI BD
LONGO DL
BAGG A
KOPP WC
JANIK JE
Citation: J. Yoe et al., DEVELOPMENT OF RHEUMATOID-ARTHRITIS AFTER TREATMENT OF LARGE GRANULARLYMPHOCYTE LEUKEMIA WITH DEOXYCOFORMYCIN, American journal of hematology, 57(3), 1998, pp. 253-257
Citation: L. Saltz et Je. Janik, TOPOTECAN AND THE TREATMENT OF RECURRENT OVARIAN-CANCER - IS THERE A ROLE FOR GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 24(1), 1997, pp. 26-30
Authors:
JANIK JS
BURRINGTON JD
JANIK JE
WAYNE ER
CHANG JHT
ROTHENBERG SS
Citation: Js. Janik et al., ANTERIOR EXPOSURE OF SPINAL DEFORMITIES AND TUMORS - A 20-YEAR EXPERIENCE, Journal of pediatric surgery, 32(6), 1997, pp. 852-859
Authors:
PRICE MR
JANIK JS
WAYNE ER
JANIK JE
MARTINEZ LA
BURRINGTON JD
Citation: Mr. Price et al., MODIFIED NISSEN FUNDOPLICATION FOR REDUCTION OF FUNDOPLICATION FAILURE, Journal of pediatric surgery, 32(2), 1997, pp. 324-327
Authors:
JANIK JE
CURTI BD
CONSIDINE RV
RAGER HC
POWERS GC
ALVORD WG
SMITH JW
GAUSE BL
KOPP WC
Citation: Je. Janik et al., INTERLEUKIN-1-ALPHA INCREASES SERUM LEPTIN CONCENTRATIONS IN HUMANS, The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 3084-3086
Authors:
JANIK JE
MILLER LL
LONGO DL
POWERS GC
URBA WJ
KOPP WC
GAUSE BL
CURTI BD
FENTON RG
OPPENHEIM JJ
CONLON KC
HOLMLUND JT
SZNOL M
SHARFMAN WH
STEIS RG
CREEKMORE SP
ALVORD WG
BEAUCHAMP AE
SMITH JW
Citation: Je. Janik et al., PHASE-II TRIAL OF INTERLEUKIN-1-ALPHA AND INDOMETHACIN IN TREATMENT OF METASTATIC MELANOMA, Journal of the National Cancer Institute, 88(1), 1996, pp. 44-49
Authors:
FENTON RG
STEIS RG
MADARA K
ZEA AH
OCHOA AC
JANIK JE
SMITH JW
GAUSE BL
SHARFMAN WH
URBA WJ
HANNA MG
DEJAGER RL
COYNE MX
CROUCH RD
GRAY P
BEVERIDGE J
CREEKMORE SP
HOLMLUND J
CURTI BD
SZNOL M
LONGO DL
Citation: Rg. Fenton et al., A PHASE-I RANDOMIZED STUDY OF SUBCUTANEOUS ADJUVANT IL-2 IN COMBINATION WITH AN AUTOLOGOUS TUMOR VACCINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 364-374
Authors:
CURTI BD
OCHOA AC
URBA WJ
ALVORD WG
KOPP WC
POWERS G
HAWK C
CREEKMORE SP
GAUSE BL
JANIK JE
HOLMLUND JT
KREMERS P
FENTON RG
MILLER L
SZNOL S
SMITH JW
SHARFMAN WH
LONGO DL
Citation: Bd. Curti et al., INFLUENCE OF INTERLEUKIN-2 REGIMENS ON CIRCULATING POPULATIONS OF LYMPHOCYTES AFTER ADOPTIVE TRANSFER OF ANTI-CD3-STIMULATED T-CELLS - RESULTS FROM A PHASE-I TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 296-308
Authors:
CURTI BD
URBA WJ
LONGO DL
JANIK JE
SHARFMAN WH
MILLER LL
CIZZA G
SHIMIZU M
OPPENHEIM JJ
ALVORD WG
SMITH JW
Citation: Bd. Curti et al., ENDOCRINE EFFECTS OF IL-1-ALPHA AND IL-1-BETA ADMINISTERED IN A PHASE-I TRIAL TO PATIENTS WITH ADVANCED CANCER, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 142-148
Authors:
GAUSE BL
SZNOL M
KOPP WC
JANIK JE
SMITH JW
STEIS RG
URBA WJ
SHARFMAN W
FENTON RG
CREEKMORE SP
HOLMLUND J
CONLON KC
VANDERMOLEN LA
LONGO DL
Citation: Bl. Gause et al., PHASE-I STUDY OF SUBCUTANEOUSLY ADMINISTERED INTERLEUKIN-2 IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2234-2241
Authors:
MILLER LL
KORN EL
STEVENS DS
JANIK JE
GAUSE BL
KOPP WC
LONGO DL
Citation: Ll. Miller et al., ABROGATION OF THE HEMATOLOGICAL ACTIVITIES OF THE GM-CSF IL-3 FUSION PROTEIN (PIXY321) BY ANTI-PIXY321 ANTIBODIES IN CANCER-PATIENTS RECEIVING HIGH-DOSE CARBOPLATIN - RESULTS OF A PHASE-I STUDY/, Journal of clinical oncology, 14(5), 1996, pp. 2012-2012
Authors:
STERNAS L
JANIK JE
DUFFEY PL
GOCKE C
REYNOLDS CW
WITTES RE
KWAK LW
Citation: L. Sternas et al., EARLY RESULTS OF A CLINICAL-TRIAL OF THERAPEUTIC VACCINATION WITH IG IDIOTYPE ANTIGEN FOR DE-NOVO FOLLICULAR LYMPHOMA, Blood, 88(10), 1996, pp. 2677-2677
Authors:
HOLMLUND JT
KOPP WC
WILTROUT RH
LONGO DL
URBA WJ
JANIK JE
SZNOL M
CONLON KC
FENTON RG
HORNUNG R
MADARA K
SHIELDS MA
SMITH JW
SHARFMAN W
STEIS RG
EWEL C
MALSPEIS L
CREEKMORE SP
Citation: Jt. Holmlund et al., A PHASE-I CLINICAL-TRIAL OF FLAVONE-8-ACETIC ACID IN COMBINATION WITHINTERLEUKIN-2, Journal of the National Cancer Institute, 87(2), 1995, pp. 134-136
Authors:
SHARFMAN WH
URBA WJ
SMITH JW
JANIK JE
CURTI BD
GAUSE BL
HOLMLUND JT
STEIS RG
BEAUCHAMP AE
LONGO DL
Citation: Wh. Sharfman et al., PHASE I II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA/, International journal of oncology, 6(3), 1995, pp. 579-583
Authors:
JANIK JE
MILLER LL
KOPP W
GAUSE B
CURTI B
LONGO DL
Citation: Je. Janik et al., A PHASE-I TRIAL OF TUMOR-NECROSIS-FACTOR (TNF) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) TO ENHANCE DENDRITIC CELL MATURATION, Journal of cellular biochemistry, 1995, pp. 11-11
Authors:
ESTEVALORENZO F
JANIK JE
FENTON RG
EMSLIESMITH A
ENGEL AG
LONGO DL
Citation: F. Estevalorenzo et al., MYOSITIS ASSOCIATED WITH INTERLEUKIN-2 THERAPY IN A PATIENT WITH METASTATIC RENAL-CELL CARCINOMA, Cancer, 76(7), 1995, pp. 1219-1223
Citation: Je. Janik et Dl. Longo, LABORATORY CHARACTERIZATION OF MALIGNANCIES OF THE IMMUNE-SYSTEM, Immunology and allergy clinics of North America, 14(2), 1994, pp. 301-322
Authors:
CURTI BD
URBA WJ
ALVORD WG
JANIK JE
SMITH JW
MADARA K
LONGO DL
Citation: Bd. Curti et al., INTERSTITIAL PRESSURE OF SUBCUTANEOUS NODULES IN MELANOMA AND LYMPHOMA PATIENTS - CHANGES DURING TREATMENT, Cancer research, 53(10), 1993, pp. 2204-2207
Authors:
JANIK JE
SZNOL M
URBA WJ
FIGLIN R
BUKOWSKI RM
FYFE G
PIERCE WC
BELLDEGRUN A
SHARFMAN WH
SMITH JW
LONGO DL
Citation: Je. Janik et al., ERYTHROPOIETIN PRODUCTION - A POTENTIAL MARKER FOR INTERLEUKIN-2 INTERFERON-RESPONSIVE TUMORS, Cancer, 72(9), 1993, pp. 2656-2659